Triple GLP-1 / GIP / glucagon receptor agonist in a ready-to-use pre-filled pen.

Long-acting amylin analogue studied in appetite regulation.
Cagrilintide is a long-acting analogue of amylin, a hormone released with insulin that signals fullness. It is studied on its own and in combination with GLP-1 agonists in metabolic research.
Read our full research review →| Compound | Cagrilintide |
| Amount | 10 mg |
| Form | Lyophilised (freeze-dried) powder in a sealed vial |
| In the box | One sealed vial |
| Quality | Independent lab test, certificate of analysis per lot |
| Storage | Before reconstitution: 2–8 °C, dry and protected from light |
| Use | Laboratory research only |
Tracked shipping worldwide from inside the EU: 2–5 working days with no customs inside the EU, usually 5–12 working days elsewhere. Nothing is charged online: a representative contacts you within 24 hours to confirm your order, then you pay by card, bank transfer or a local method. More details
For laboratory research use only. Not a medicine and not for human or veterinary use. Not approved by the EMA, FDA or any other regulator. Sold to adults 18+.
No account and no card. You leave your number, a real person calls, and you pay only once everything is clear.
Choose the quantity. Nothing is charged.
Name and phone at checkout, about 30 seconds.
Within 24 hours, by phone or WhatsApp. Ask for the lot certificate.
Card, transfer or a local method. Tracked box from the EU.
Triple GLP-1 / GIP / glucagon receptor agonist in a ready-to-use pre-filled pen.
Triple GLP-1 / GIP / glucagon receptor agonist, 10 mg lyophilised peptide vial.
Modified fragment of the growth-hormone C-terminus studied in fat metabolism.